The Apheresis Systems Market is projected to be valued at over US $4.2 billion by the end of 2033 and is expected to record a CAGR of over 6.97% during the forecast period of 2025-2033. The therapeutic apheresis market is expanding due to rising demand in autoimmune disorders, hematologic diseases, and oncology, along with advancements in cell separation technologies. Increased use of plasma exchange, stem cell collection, and more blood donation centers worldwide are also key factors driving this growth.
Apheresis system is very helpful when it comes to collection and separation of blood components that are necessary for donation. Additionally, it also assists in removing or exchanging blood components for the purpose of therapy. The plasma or platelets are separated and collected when the red blood cells are returned back into the bloodstream of the donor. Depending on the blood constituents that undergo centrifugation, there are various types of procedures such as platelets (plateletphersis), plasma (plasmapheresis), lymphocytes (lymphophersis or lymphaphersis), leukocytes (leukaphersis) and red blood cells (erythrophersis). This procedure can also be implemented for therapy where the diseased blood component is removed while the healthy blood component is returned back into the circulation of the patient. Additionally, this procedure can also be used for the purpose of stem cell harvesting.
The increasing importance of apheresis systems in blood component separation in therapeutics procedure fuelled the growth of the market. It is commonly used for severe rheumatoid arthritis, Goodpasture syndrome, leukostasis, systemic lupus, and others. It is also used to reduce the risk of the antibody-mediated immune response during organ transplantation. So, it has significant importance in the healthcare setting in lifesaving interventions. It is further supported by the rapid advancement of technologies and led to the rapid evolution of continuous units for simultaneous blood collection and removal. Additionally, recent advancements decreased complications associated and made it more advantageous over the traditional methods. Further, increasing healthcare expenditure by both private and public sectors to incorporate advanced technologies created huge opportunities for market growth.
Automation and Mobility: Automation and mobility have become key trends in the apheresis equipment market. In 2023, automated cell separation machines represented 76% of all installations, showing an 11% increase compared to the previous year. Additionally, sales of portable apheresis units, which are perfect for mobile donation drives, grew by 19%.